Aislinn Antrim, MA, Assistant Managing Editor

If half of the US population is vaccinated by the summer rather than the fall, 5.8 million cases of COVID-19 could be prevented.

The incidence of colorectal cancer in adults between the ages of 40 and 49 years has increased by nearly 15% since 2000.

Study participants who fasted 2 days per week reported fewer scaling and thickening, with 30% also reporting a decrease in itching associated with psoriasis.

The trial found positive results in both the overall study population of patients with advanced cervical cancer as well as subgroups with squamous cell carcinoma and adenocarcinoma.

As breast cancer becomes an increasingly treatable disease, clinicians should provide personalized follow-up care to address varying burdens of symptoms up to 5 years after diagnosis.

The institution joins 3 other ACPE-accredited pharmacy programs in North Carolina.

High engagement and collaboration between health systems and health plans is essential to implementing value-based models, according to a session at the Pharmacy Quality Alliance 2021 Annual Conference.

Policy changes impacting the star ratings for 2022 include additional flexibility provided during the COVID-19 pandemic and a revised Extreme and Uncontrollable Circumstances policy.

The KEYNOTE-522 trial met its dual primary endpoints of pathologic complete response and event-free survival, showing a statistically significant and clinically meaningful improvement in EFS compared to neoadjuvant chemotherapy alone.

Pharmacists can play a direct role in addressing social disparities of health in low-income communities by building trust and providing expertise to patients.

A lack of pharmacies in minority neighborhoods may be contributing to persistent racial and ethnic health disparities, even in the largest cities in the United States.

Experts estimate that 60% of adults have insufficient levels of vitamin D, which is known to promote bone and soft tissue health.

Further integration with care teams and using data to demonstrate the value of pharmacists will be essential to maintaining the momentum created by the COVID-19 pandemic.

Models without the Gastrokine-1 protein weigh less and had lower levels of total body fat, despite consuming the same amount of food.

Research is ongoing in younger children between the ages of 6 months and 11 years of age, with first doses administered in March 2021.

These findings also suggest that the efficacy of radiotherapy can be improved with drugs that block the PDGFRb protein.

Although it is currently used off-label for many neuroinflammatory and neurodegenerative disorders, intravenous immunoglobulin is showing promise for a growing number of neurological diseases.

Obstacles such as COVID-19 vaccine rollout disparities, vaccine hesitancy, and continuous virus mutation could make herd immunity impossible.

Overdose rates were two and a half times higher among patients who filled an opioid prescription following a dental procedure.

The companies have also submitted an application to expand the current EUA for the COVID-19 vaccine to include individuals 12 to 15 years of age.

More than half of participants in the MDMA-assisted therapy arm no longer qualified for a post-traumatic stress disorder diagnosis after 3 sessions, compared to 32% in the control arm.

Although prolonged COVID-19 infections are rare, even in children or young adults with compromised immunity, it could have public health implications.

Not all CD4+ T cells are equally susceptible to infection in vivo, which could suggest that the most susceptible cells could eventually become targets of preventive interventions.

Although young women were the original targets of human papillomavirus vaccine outreach after its approval in 2006, the increasing rates oropharyngeal cancer has made vaccination for young men even more important.

The proposal would also distribute 1000 additional physician residency slots to hospitals in rural areas in an effort to address gaps in equitable care.

The approval of dapagliflozin is the most significant advancement in the treatment of chronic kidney disease in more than 20 years, according to a press release.

The FDA hold was announced in December 2020 following the diagnosis of one patient with hepatocellular carcinoma in the HOPE-B pivotal trial.

Although therapeutics and vaccines for COVID-19 have dominated the news in the last year, development of other drugs has continued.

In addition to altered supply chains and medication access during the early months of the pandemic, the report predicts long-term changes for both COVID-19 survivors and those with chronic illnesses.

Although transthyretin can play a negative role in patients with amyloidosis, it may have protective effects in patients with Alzheimer disease.